4He J, Klag M J, Caballero B, et al. Plasma insulin level and incidence of hypertension in African Americans and whites [J], Arch InterMed, 1999, 159:498-503.
5Stumvoll M, Mitrakou A, Pzmenta W, Use of the oral glucose, Tolerance test to assess insulin sensitivity [ J ], Diabetes Care, 2000, 23:295-301.
6Clark RB, Bishop Bailey D, Estrada hemandez T, et al. The nuclearl receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses [J]. J Immunol, 2000, 164:1364-1371.
7Kemnitz JW, Elson DF, Roecker EB, et al. Pioglitazone, increase insulinsensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood Pressure:in obese, insulin resistant rhesusmonkeys [J]. Diabetes, 1994, 43(2):204-211.
8Zang M,Zuccollo A,Hou X,et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulinresistant human HepG2 cells[J]. J Biol Chem, 2004,279(46); 47898-47905.
9POOLE-WILSON PA, SWEDBERG K, CLELAND JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial(COMET):randomised controlled trial [J]. Lancet, 2003, 362(9377): 7-13.
10BAKRIS GL, FONSECA V, KATHOLI RE, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension, A randomized controlled trial[J]. JAMA, 2004, 292 ( 18 ) : 2227-2236.
